Filing Details
- Accession Number:
- 0001209191-19-046031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-15 08:42:28
- Reporting Period:
- 2019-07-31
- Accepted Time:
- 2019-08-15 08:42:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Lineage Cell Therapeutics Inc. | LCTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1777467 | C. Chase Leavitt | C/O Lineage Cell Therapeutics, Inc. 2173 Salk Avenue, Suite 200 Carlsbad CA 92008 | General Counsel/Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2019-08-13 | 5,000 | $1.02 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Employee Stock Option (Right to Buy) | Acquisiton | 2019-07-31 | 125,000 | $0.00 | 125,000 | $1.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 125,000 | 2029-07-30 | No | 4 | A | Direct |
Footnotes
- One quarter of the options shall vest on May 20, 2020 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
Billionaire Hedge Funds
